From February 28 to March 1, 2025, the annual marketing conference of Endoso Life, which is expected by all marketing teams at home and abroad, was successfully held at the headquarters of Endoso in Hangzhou. Sales elites from all over the country gathered to share experience, exchange ideas, and jointly explore new directions and new opportunities for business development.


This conference focused on the brand, from the industry and product knowledge, market access, bidding, clinical service, after-sales service, academic promotion and financial management and other key dimensions, a comprehensive and in-depth introduction. In addition, the annual outstanding Employee award ceremony was held at the conference, and employees with outstanding performance in the past year were commended and rewarded.


By 2024, the company has achieved strategic results in market expansion, with more than 20 products approved for listing and highly recognized by the industry, domestic and overseas clinicians, industry experts, and the capital market. In 2025, Endoso Life will maintain its original intention, adhere to independent research and development, focus on clinical practice, and contribute to the development of China's minimally invasive diagnosis and treatment industry.


In the future, Endoso Life will maintain its original intention, adhere to the demands of doctors and patients in the first place, adhere to independent research and development, focus on clinical, and meet clinical and patient needs with high-quality products and services